Probiotic use may decrease risk factors for metabolic syndrome
1. Patients randomized to receive 12 weeks of Lacticaseibacillus paracasei MSMC39-1 and Bifidobacterium animalis TA-1 probiotics were observed to have...
Endocrinology
Reports of high-impact endocrinology studies by medical professionals
Glucagon-like peptide-1 receptor agonists and co-agonists safe and effective for weight loss
1. In this systematic review, glucagon-like peptide-1 receptor agonists and co-agonists were effective in inducing weight loss in overweight adults...
Poor glycemic control may not be associated with increased outpatient antibiotic prescription rates
1. HbA1C levels were not associated with the number of antibiotic prescriptions in type 2 diabetic patients followed at primary...
Dyslipidemia contributes to greater incidence of diabetic kidney disease
The ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol is associated with diabetic kidney disease: A cross-sectional study 1....
Suboptimal glycemic index management is negatively associated with male fertility
1. Suboptimal carbohydrate consumption is negatively associated with male fertility but not female fertility Evidence Rating Level: 3 (Average) Subfertility...
Weight loss interventions may improve metabolic and reproductive outcomes in polycystic ovarian syndrome
1. In this systematic review and meta-analysis, weight loss interventions for overweight people with polycystic ovary syndrome were associated with...
Glucagon-like peptide-1 receptor agonists may impact outcomes of endoscopy
1. The use of glucagon-like peptide 1 (GLP-1) receptor agonists in adults with type 2 diabetes mellitus (T2DM) was not...
Weekly insulin efsitora alfa is non-inferior to daily insulin degludec for reducing HbA1c in type 1 diabetes
1. Once weekly efsitora demonstrated non-inferiority compared with degludec with regards to change in HbA1c. 2. Patients in the efsitora...
![Type I diabetes not associated with early menopause [OVADIA study]](https://www.2minutemedicine.com/wp-content/uploads/2014/12/diabetes1_edited-350x250.jpg)
Risk factors for diabetes in people with HIV
1. This follow-up analysis of the phase 3 REPRIEVE trial demonstrated that region of residence, prediabetes, high BMI, and metabolic...
Crinecerfont decreases glucocorticoid use in adults with congenital adrenal hyperplasia
1. In this randomized controlled trial, twice daily crinecerfont use was associated with reduced daily glucocorticoid use in adults with...